ATE453659T1 - Verfahren zur herstellung von 7-alpha- methylsteroide - Google Patents

Verfahren zur herstellung von 7-alpha- methylsteroide

Info

Publication number
ATE453659T1
ATE453659T1 AT03702441T AT03702441T ATE453659T1 AT E453659 T1 ATE453659 T1 AT E453659T1 AT 03702441 T AT03702441 T AT 03702441T AT 03702441 T AT03702441 T AT 03702441T AT E453659 T1 ATE453659 T1 AT E453659T1
Authority
AT
Austria
Prior art keywords
alpha
producing
methyl steroids
steroids
methyl
Prior art date
Application number
AT03702441T
Other languages
English (en)
Inventor
J Stoelwinder
M Ostendorf
Van P A M Buggenum
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of ATE453659T1 publication Critical patent/ATE453659T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
AT03702441T 2002-01-21 2003-01-14 Verfahren zur herstellung von 7-alpha- methylsteroide ATE453659T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075230 2002-01-21
PCT/EP2003/000339 WO2003059931A1 (en) 2002-01-21 2003-01-14 PROCESS FOR THE PREPARATION OF 7α-METHYLSTEROIDS

Publications (1)

Publication Number Publication Date
ATE453659T1 true ATE453659T1 (de) 2010-01-15

Family

ID=8185555

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03702441T ATE453659T1 (de) 2002-01-21 2003-01-14 Verfahren zur herstellung von 7-alpha- methylsteroide

Country Status (28)

Country Link
US (2) US20050090476A1 (de)
EP (1) EP1470151B1 (de)
JP (1) JP5250174B2 (de)
KR (1) KR100937179B1 (de)
CN (1) CN100372864C (de)
AR (1) AR038165A1 (de)
AT (1) ATE453659T1 (de)
AU (1) AU2003205604B8 (de)
BR (1) BRPI0306736B8 (de)
CA (1) CA2472379C (de)
DE (1) DE60330749D1 (de)
EC (1) ECSP045180A (de)
EG (1) EG23417A (de)
ES (1) ES2336439T3 (de)
HR (1) HRP20040634B1 (de)
IL (2) IL162770A0 (de)
IS (1) IS2740B (de)
MX (1) MXPA04007049A (de)
NO (1) NO327095B1 (de)
NZ (1) NZ533970A (de)
PE (1) PE20030926A1 (de)
PL (1) PL208163B1 (de)
RO (1) RO122913B1 (de)
RS (1) RS51490B (de)
RU (1) RU2305105C2 (de)
TW (1) TWI322813B (de)
WO (1) WO2003059931A1 (de)
ZA (1) ZA200405257B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10213371C1 (de) * 2002-03-21 2003-12-24 Schering Ag Verfahren zur Herstellung von 7alpha-Methylsteroiden
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
DE10352433B4 (de) 2003-11-10 2012-10-11 Nanotecmarin Gmbh Polypeptid eines Silicatein-ß aus Suberites domuncula, dafür kodierende Nukleinsäure, deren Verwendungen, diese Nukleinsäure umfassender Vektor und dieses Polypeptid exprimierende Wirtszelle
KR100716981B1 (ko) * 2004-09-30 2007-05-10 삼성전자주식회사 대중교통의 최적경로 검색방법 및 이를 이용한 휴대용 기기
US20130123541A1 (en) * 2009-06-29 2013-05-16 Merz Pharma Gmbh & Co. Kgaa Method of preparing 3,3,5,5-tetramethylcyclohexanone
CN111944001A (zh) * 2020-07-09 2020-11-17 浙江神洲药业有限公司 一种替勃龙的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341557A (en) * 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3470216A (en) * 1966-11-29 1969-09-30 Du Pont Selected 17,17-difluoro unsaturated androstanes
FR2054527B1 (de) * 1969-07-28 1973-06-08 Roussel Uclaf
US3798213A (en) * 1971-01-25 1974-03-19 Merck & Co Inc 7 alpha-methyl-20-spiroxane-3-ones and process
DE2558088C2 (de) * 1975-12-19 1985-05-30 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 4-Androsten-3,17-dion-Derivaten
JPS56145239A (en) * 1980-04-11 1981-11-11 Sumitomo Chem Co Ltd Novel bicyclooctane derivative and its preparation
US4298559A (en) * 1980-07-23 1981-11-03 Dow Corning Corporation High yield silicon carbide from alkylated or arylated pre-ceramic polymers
US6548491B2 (en) * 1997-12-24 2003-04-15 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
TW548277B (en) * 1999-07-16 2003-08-21 Akzo Nobel Nv Orally active androgens
WO2001040255A2 (en) * 1999-12-02 2001-06-07 Akzo Nobel N.V. 14,15-beta-methylene substituted androgens
US6784170B2 (en) * 2000-02-11 2004-08-31 Sri International Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one
BR0112791A (pt) * 2000-07-28 2003-06-24 Akzo Nobel Nv Composto esteroidal 16alfa-substituido, uso do mesmo, métodos de tratamento para ativação seletiva de receptores de estrogênio do subtipo alfa, e para terapia de reposição hormonal ou contracepção, e, composição farmacêutica
US20040010138A1 (en) * 2002-03-21 2004-01-15 Schering Ag Process for the production of 7alpha-methyl steroids
US7304157B2 (en) * 2004-09-28 2007-12-04 Bristol-Myers Squibb Company Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

Also Published As

Publication number Publication date
EG23417A (en) 2005-06-28
EP1470151B1 (de) 2009-12-30
RO122913B1 (ro) 2010-04-30
RU2004125580A (ru) 2006-01-27
IL162770A0 (en) 2005-11-20
AU2003205604A1 (en) 2003-07-30
AU2003205604B2 (en) 2009-11-26
RS51490B (sr) 2011-04-30
ZA200405257B (en) 2005-08-31
ECSP045180A (es) 2004-08-27
US20100204497A1 (en) 2010-08-12
BRPI0306736B8 (pt) 2021-05-25
KR20040077727A (ko) 2004-09-06
AU2003205604B8 (en) 2009-12-24
CA2472379C (en) 2010-05-25
IL162770A (en) 2011-06-30
NO327095B1 (no) 2009-04-20
TWI322813B (en) 2010-04-01
PE20030926A1 (es) 2003-10-29
KR100937179B1 (ko) 2010-01-19
JP5250174B2 (ja) 2013-07-31
PL371583A1 (en) 2005-06-27
EP1470151A1 (de) 2004-10-27
DE60330749D1 (de) 2010-02-11
US20050090476A1 (en) 2005-04-28
BRPI0306736B1 (pt) 2017-11-07
AR038165A1 (es) 2004-12-29
YU63004A (sh) 2006-08-17
CA2472379A1 (en) 2003-07-24
TW200302731A (en) 2003-08-16
NO20043455L (no) 2004-08-19
JP2005519899A (ja) 2005-07-07
ES2336439T3 (es) 2010-04-13
HRP20040634B1 (hr) 2013-07-31
HRP20040634A2 (en) 2004-10-31
CN1863814A (zh) 2006-11-15
RU2305105C2 (ru) 2007-08-27
NZ533970A (en) 2005-10-28
BR0306736A (pt) 2004-12-28
IS2740B (is) 2011-06-15
IS7339A (is) 2004-06-28
MXPA04007049A (es) 2004-10-14
PL208163B1 (pl) 2011-03-31
WO2003059931A1 (en) 2003-07-24
CN100372864C (zh) 2008-03-05

Similar Documents

Publication Publication Date Title
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
ATE408609T1 (de) Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden
ATE515500T1 (de) Verfahren zur herstellung von telmisartan
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
ATA11912002A (de) Verfahren zur herstellung von fälschungssicheren identifikationsmerkmalen
DE60327788D1 (de) Verfahren zur herstellung von polytrimethylenterephthalt-fasern
ATE315099T1 (de) Verfahren zur herstellung von tagatose
ATE308524T1 (de) Verfahren zur herstellung von aripiprazole
DE50308650D1 (de) Verfahren zur herstellung von cellulosecarbamatformkörpern
DE60330050D1 (de) Verfahren zur herstellung von pyrimidinverbindungen
ATE553103T1 (de) Verfahren zur herstellung von (s)-pantoprazol
ATE456569T1 (de) Verfahren zur herstellung von 6-alkyliden- penemderivaten
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten
DE602004000126D1 (de) Verfahren zur Herstellung von selbststanzenden Muttern
ATE336478T1 (de) Verfahren zur herstellung von benzophenonen
ATE453619T1 (de) Verfahren zur herstellung von hydroperoxiden
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
DE60210911D1 (de) Verfahren zur Herstellung von dehnungserfassenden Vorrichtungen
DE502004004318D1 (de) Verfahren zur herstellung von metall-matrix-verbundwerkstoffen
DE50200870D1 (de) Verfahren zur herstellung von hydroxyalkylpolysiloxanen
ATE402138T1 (de) Verfahren zur herstellung von 2- aminoindanderivaten
ATE371642T1 (de) Verfahren zur herstellung von 3- methylthiopropanal
DE60336173D1 (de) Verfahren zur herstellung von vanadylpyrophosphat-katalysatoren
ATE549314T1 (de) Verfahren zur herstellung von 4-aminochinazolinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties